XML 80 R53.htm IDEA: XBRL DOCUMENT v3.6.0.2
Acquisition of BioNovion Holding, B.V. - Summary of Pro Forma Financial Information (Details) - Aduro Biotech Europe - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Business Acquisition [Line Items]    
Revenue $ 78,272 $ 19,944
Net loss $ (39,520) $ (19,390)
Basic and diluted net loss per share $ (0.76) $ (24.31)